Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression

Pharmacology and Therapeutics

Volumn 137, Issue 2, 2013, Pages 153-171

  Lee, Jong Hun ^a   Khor, Tin Oo ^a   Shu, Limin ^a   Su, Zheng Yuan ^a   Fuentes, Francisco ^a,b   Kong, Ah Ng Tony ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSIDAD ARTURO PRAT   (Chile)

Author keywords

Antioxidant response; Cancer stem cell; Dietary phytochemical; Epigenetics; Inflammation; Nrf2

Indexed keywords

(6) GINGEROL; 3 INDOLEMETHANOL; ANACARDIC ACID; BENZYL ISOTHIOCYANATE; CAFFEIC ACID; CHLOROGENIC ACID; CURCUMIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; GLYCOGEN SYNTHASE KINASE 3; LYCOPENE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PHENETHYL ISOTHIOCYANATE; PLANT MEDICINAL PRODUCT; QUERCETIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RESVERATROL; STAT3 PROTEIN; SULFORAPHANE; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR NRF2;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; CANCER INHIBITION; CANCER PREVENTION; CANCER STEM CELL; CARCINOGENESIS; CHEMOPROPHYLAXIS; DNA METHYLATION; EPIGENETICS; GENE MUTATION; HISTONE MODIFICATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; DIET; DISEASE PROGRESSION; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHYTOTHERAPY; SIGNAL TRANSDUCTION;

EID: 84872813218     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.09.008     Document Type: Review

References (298)

1. C.A. Afshari, E.F. Nuwaysir, and J.C. Barrett Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation Cancer Res 59 1999 4759 4760
2. B.B. Aggarwal, A.B. Kunnumakkara, K.B. Harikumar, S.R. Gupta, S.T. Tharakan, and C. Koca Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171 2009 59 76
3. J. Alam, C. Wicks, D. Stewart, P. Gong, C. Touchard, and S. Otterbein Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor J Biol Chem 275 2000 27694 27702
4. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 2003 3983 3988
5. A. Ashkenazi, and V.M. Dixit Death receptors: signaling and modulation Science 281 1998 1305 1308
6. B.M. Babior Phagocytes and oxidative stress Am J Med 109 2000 33 44
7. S. Balasubramanian, G. Adhikary, and R.L. Eckert The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival Carcinogenesis 31 2010 496 503
8. S. Balasubramanian, Y.C. Chew, and R.L. Eckert Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells Mol Pharmacol 80 2011 870 878
9. E. Balogun, M. Hoque, P. Gong, E. Killeen, C.J. Green, and R. Foresti Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element Biochem J 371 2003 887 895
10. T.R. Balstad, H. Carlsen, M.C.W. Myhrstad, M. Kolberg, H. Reiersen, and L. Gilen Coffee, broccoli and spices are strong inducers of electrophile response element-dependent transcription in vitro and in vivo - studies in electrophile response element transgenic mice Mol Nutr Food Res 55 2011 185 197
11. D. Baltimore, M.P. Boldin, R.M. O'Connell, D.S. Rao, and K.D. Taganov MicroRNAs: new regulators of immune cell development and function Nat Immunol 9 2008 839 845
12. G. Bandyopadhyay, T. Biswas, K.C. Roy, S. Mandal, C. Mandal, and B.C. Pal Chlorogenic acid-inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells Blood 104 2004 2514 2522
13. S. Banerjee, Y.X. Zhang, S. Ali, M. Bhuiyan, Z.W. Wang, and P.J. Chiao Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer Cancer Res 65 2005 9064 9072
14. A. Barski, S. Cuddapah, K. Cui, T.Y. Roh, D.E. Schones, and Z. Wang High-resolution profiling of histone methylations in the human genome Cell 129 2007 823 837
15. A. Barve, T.O. Khor, S. Nair, W. Lin, S. Yu, and M.R. Jain Pharmacogenomic profile of soy isoflavone concentrate in the prostate of Nrf2 deficient and wild-type mice J Pharm Sci 97 2008 4528 4545
16. A. Barve, T.O. Khor, K. Reuhl, B. Reddy, H. Newmark, and A.N. Kong Mixed tocotrienols inhibit prostate carcinogenesis in TRAMP mice Nutr Cancer 62 2010 789 794
17. S.B. Baylin, M. Makos, J.J. Wu, R.W. Yen, A. de Bustros, and P. Vertino Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression Cancer Cells 3 1991 383 390
18. K.B. Beckman, and B.N. Ames The free radical theory of aging matures Physiol Rev 78 1998 547 581
19. L. Becks, M. Prince, H. Burson, C. Christophe, M. Broadway, and K. Itoh Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene BMC Cancer 10 2010 540
20. M.T. Bedford, and P.D. van Helden Hypomethylation of DNA in pathological conditions of the human prostate Cancer Res 47 1987 5274 5276
21. S.L. Berger The complex language of chromatin regulation during transcription Nature 447 2007 407 412
22. L. Berlowitz, and D. Pallotta Acetylation of nuclear protein in the heterochromatin and euchromatin of mealy bugs Exp Cell Res 71 1972 45 48
23. S.R. Bhaumik, E. Smith, and A. Shilatifard Covalent modifications of histones during development and disease pathogenesis Nat Struct Mol Biol 14 2007 1008 1016
24. A. Bird DNA methylation patterns and epigenetic memory Genes Dev 16 2002 6 21
25. D.A. Bloom, and A.K. Jaiswal Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression J Biol Chem 278 2003 44675 44682
26. A.M. Bode, and Z. Dong The functional contrariety of JNK Mol Carcinog 46 2007 591 598
27. D. Boivin, D. Labbe, N. Fontaine, S. Lamy, E. Beaulieu, and D. Gingras The stem cell marker CD133 (Prominin-1) is phosphorylated on cytoplasmic Tyrosine-828 and Tyrosine-852 by Src and Fyn tyrosine kinases Biochemistry 48 2009 3998 4007
28. J.E. Bolden, M.J. Peart, and R.W. Johnstone Anticancer activities of histone deacetylase inhibitors Nat Rev Drug Discov 5 2006 769 784
29. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 1997 730 737
30. J.F. Bromberg, M.H. Wrzeszczynska, G. Devgan, Y. Zhao, R.G. Pestell, and C. Albanese Stat3 as an oncogene Cell 98 1999 295 303
31. B.M. Burgering, and J.L. Bos Regulation of Ras-mediated signalling: more than one way to skin a cat Trends Biochem Sci 20 1995 18 22
32. J. Busciglio, and B.A. Yankner Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro Nature 378 1995 776 779
33. M. Carleton, M.A. Cleary, and P.S. Linsley MicroRNAs and cell cycle regulation Cell Cycle 6 2007 2127 2132
34. B.I. Carr, J.G. Reilly, S.S. Smith, C. Winberg, and A. Riggs The tumorigenicity of 5-azacytidine in the male Fischer rat Carcinogenesis 5 1984 1583 1590
35. X. Carvajal-Vergara, S. Tabera, J.C. Montero, A. Esparis-Ogando, R. Lopez-Perez, and G. Mateo Multifunctional role of Erk5 in multiple myeloma Blood 105 2005 4492 4499
36. H.Z. Chae, S.W. Kang, and S.G. Rhee Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin Methods Enzymol 300 1999 219 226
37. L. Chang, and M. Karin Mammalian MAP kinase signalling cascades Nature 410 2001 37 40
38. E. Charafe-Jauffret, F. Monville, C. Ginestier, G. Dontu, D. Birnbaum, and M.S. Wicha Cancer stem cells in breast: current opinion and future challenges Pathobiology 75 2008 75 84
39. Y.R. Chen, J. Han, R. Kori, A.N. Kong, and T.H. Tan Phenylethyl isothiocyanate induces apoptotic signaling via suppressing phosphatase activity against c-Jun N-terminal kinase J Biol Chem 277 2002 39334 39342
40. T.J. Chen, J.Y. Jeng, C.W. Lin, C.Y. Wu, and Y.C. Chen Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells Toxicology 223 2006 113 126
41. C. Chen, and A.N. Kong Dietary chemopreventive compounds and ARE/EpRE signaling Free Radic Biol Med 36 2004 1505 1516
42. C. Chen, and A.N. Kong Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects Trends Pharmacol Sci 26 2005 318 326
43. K.L. Cheung, T.O. Khor, M.T. Huang, and A.N. Kong Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM Carcinogenesis 31 2010 880 885
44. K.L. Cheung, T.O. Khor, and A.N. Kong Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation Pharm Res 26 2009 224 231
45. K. Cheung, and A.-N. Kong Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention AAPS J 12 2010 87 97
46. J.Y. Cheung, R.C. Ong, Y.K. Suen, V. Ooi, H.N. Wong, and T.C. Mak Polyphyllin D is a potent apoptosis inducer in drug-resistant HepG2 cells Cancer Lett 217 2005 203 211
47. S.R. Chinni, Y.W. Li, S. Upadhyay, P.K. Koppolu, and F.H. Sarkar Indole3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells Oncogene 20 2001 2927 2936
48. S.R. Chinni, and F.H. Sarkar Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells Clin Cancer Res 8 2002 1228 1236
49. J.M. Chow, S.C. Shen, S.K. Huan, H.Y. Lin, and Y.C. Chen Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages Biochem Pharmacol 69 2005 1839 1851
50. M.F. Clarke, J.E. Dick, P.B. Dirks, C.J. Eaves, C.H. Jamieson, and D.L. Jones Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells Cancer Res 66 2006 9339 9344
51. M.F. Clarke, and M. Fuller Stem cells and cancer: two faces of eve Cell 124 2006 1111 1115
52. M.H. Cobb, and E.J. Goldsmith How MAP kinases are regulated J Biol Chem 270 1995 14843 14846
53. F. Correa, C. Mallard, M. Nilsson, and M. Sandberg Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3beta Neurobiol Dis 44 2011 142 151
54. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
55. S. Crettol, N. Petrovic, and M. Murray Pharmacogenetics of phase I and phase II drug metabolism Curr Pharm Des 16 2010 204 219
56. C.M. Croce Causes and consequences of microRNA dysregulation in cancer Nat Rev Genet 10 2009 704 714
57. A.K. Croker, and A.L. Allan Cancer stem cells: implications for the progression and treatment of metastatic disease J Cell Mol Med 12 2008 374 390
58. S.B. Cullinan, and J.A. Diehl PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress J Biol Chem 279 2004 20108 20117
59. N.N. Danial, and S.J. Korsmeyer Cell death: critical control points Cell 116 2004 205 219
60. E.S. Diala, M.S. Cheah, D. Rowitch, and R.M. Hoffman Extent of DNA methylation in human tumor cells J Natl Cancer Inst 71 1983 755 764
61. M. Ding, J. Zhao, L. Bowman, Y. Lu, and X. Shi Inhibition of AP-1 and MAPK signaling and activation of Nrf2/ARE pathway by quercitrin Int J Oncol 36 2010 59 67
62. D.C. Dolinoy, J.R. Weidman, and R.L. Jirtle Epigenetic gene regulation: linking early developmental environment to adult disease Reprod Toxicol 23 2007 297 307
63. G. Dontu, W.M. Abdallah, J.M. Foley, K.W. Jackson, M.F. Clarke, and M.J. Kawamura In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells Genes Dev 17 2003 1253 1270
64. S.E. Egan, B.W. Giddings, M.W. Brooks, L. Buday, A.M. Sizeland, and R.A. Weinberg Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation Nature 363 1993 45 51
65. L. Ellis, P.W. Atadja, and R.W. Johnstone Epigenetics in cancer: targeting chromatin modifications Mol Cancer Ther 8 2009 1409 1420
66. M. Esteller CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future Oncogene 21 2002 5427 5440
67. M. Esteller Epigenetic gene silencing in cancer: the DNA hypermethylome Hum Mol Genet 16 Spec No 1 2007 R50 R59
68. M. Esteller Epigenetics in cancer N Engl J Med 358 2008 1148 1159
69. J.W. Fahey, X. Haristoy, P.M. Dolan, T.W. Kensler, I. Scholtus, and K.K. Stephenson Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors Proc Natl Acad Sci U S A 99 2002 7610 7615
70. M.Z. Fang, Y. Wang, N. Ai, Z. Hou, Y. Sun, and H. Lu Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines Cancer Res 63 2003 7563 7570
71. E.O. Farombi, S. Shrotriya, H.-K. Na, S.-H. Kim, and Y.-J. Surh Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1 Food Chem Toxicol 46 2008 1279 1287
72. A.P. Feinberg, C.W. Gehrke, K.C. Kuo, and M. Ehrlich Reduced genomic 5-methylcytosine content in human colonic neoplasia Cancer Res 48 1988 1159 1161
73. A.P. Feinberg, R. Ohlsson, and S. Henikoff The epigenetic progenitor origin of human cancer Nat Rev Genet 7 2006 21 33
74. Q. Feng, and Y. Zhang The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes Genes Dev 15 2001 827 832
75. J.W. Finley, A.-N. Kong, K.J. Hintze, E.H. Jeffery, L.L. Ji, and X.G. Lei Antioxidants in foods: state of the science important to the food industry J Agric Food Chem 59 2011 6837 6846
76. W. Fischle, Y. Wang, S.A. Jacobs, Y. Kim, C.D. Allis, and S. Khorasanizadeh Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains Genes Dev 17 2003 1870 1881
77. S.P. Fodor, R.P. Rava, X.C. Huang, A.C. Pease, C.P. Holmes, and C.L. Adams Multiplexed biochemical assays with biological chips Nature 364 1993 555 556
78. M.F. Fraga, E. Ballestar, A. Villar-Garea, M. Boix-Chornet, J. Espada, and G. Schotta Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer Nat Genet 37 2005 391 400
79. M.A. Gama-Sosa, V.A. Slagel, R.W. Trewyn, R. Oxenhandler, K.C. Kuo, and C.W. Gehrke The 5-methylcytosine content of DNA from human tumors Nucleic Acids Res 11 1983 6883 6894
80. D. Gerhold, T. Rushmore, and C.T. Caskey DNA chips: promising toys have become powerful tools Trends Biochem Sci 24 1999 168 173
81. D. Germain, and D.A. Frank Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy Clin Cancer Res 13 2007 5665 5669
82. S. Goodison, V. Urquidi, and D. Tarin CD44 cell adhesion molecules Mol Pathol 52 1999 189 196
83. S. Griffiths-Jones, R.J. Grocock, S. van Dongen, A. Bateman, and A.J. Enright miRBase: microRNA sequences, targets and gene nomenclature Nucleic Acids Res 34 2006 D140 D144
84. M. Haberland, R.L. Montgomery, and E.N. Olson The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nat Rev Genet 10 2009 32 42
85. B. Halliwell, and J. Gutteridge Free Radicals in Biology and Medicine 1999 Oxford University Press Oxford, UK
86. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
87. D. Harman Aging: a theory based on free radical and radiation chemistry J Gerontol 11 1956 298 300
88. J.D. Hayes, and M. McMahon NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer Trends Biochem Sci 34 2009 176 188
89. L. He, and G.J. Hannon MicroRNAs: small RNAs with a big role in gene regulation Nat Rev Genet 5 2004 522 531
90. X. He, G.X. Lin, M.G. Chen, J.X. Zhang, and Q. Ma Protection against chromium (VI)-induced oxidative stress and apoptosis by Nrf2. Recruiting Nrf2 into the nucleus and disrupting the nuclear Nrf2/Keap1 association Toxicol Sci 98 2007 298 309
91. H.D. Hemmati, I. Nakano, J.A. Lazareff, M. Masterman-Smith, D.H. Geschwind, and M. Bronner-Fraser Cancerous stem cells can arise from pediatric brain tumors Proc Natl Acad Sci U S A 100 2003 15178 15183
92. B. Hendrich, and A. Bird Identification and characterization of a family of mammalian methyl-CpG binding proteins Mol Cell Biol 18 1998 6538 6547
93. A. Herbst, K. Rahmig, P. Stieber, A. Philipp, A. Jung, and A. Ofner Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer Am J Gastroenterol 106 2011 1110 1118
94. F. Hernandez, E. Gomez de Barreda, A. Fuster-Matanzo, J.J. Lucas, and J. Avila GSK3: a possible link between beta amyloid peptide and tau protein Exp Neurol 223 2010 322 325
95. M. Hibi, A. Lin, T. Smeal, A. Minden, and M. Karin Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain Genes Dev 7 1993 2135 2148
96. K.P. Hoeflich, J. Luo, E.A. Rubie, M.S. Tsao, O. Jin, and J.R. Woodgett Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation Nature 406 2000 86 90
97. F. Hong, M.L. Freeman, and D.C. Liebler Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane Chem Res Toxicol 18 2005 1917 1926
98. Y. Hu, Y. Ju, D. Lin, Z. Wang, Y. Huang, and S. Zhang Mutation of the Nrf2 gene in non-small cell lung cancer Mol Biol Rep 39 4 2012 4743 4747 (Electronic publication ahead of print)
99. R. Hu, C. Xu, G. Shen, M.R. Jain, T.O. Khor, and A. Gopalkrishnan Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice Cancer Lett 243 2006 170 192
100. R. Hu, C. Xu, G. Shen, M.R. Jain, T.O. Khor, and A. Gopalkrishnan Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray Life Sci 79 2006 1944 1955
101. P. Huang, J. Han, and L. Hui MAPK signaling in inflammation-associated cancer development Protein Cell 1 2010 218 226
102. H.C. Huang, T. Nguyen, and C.B. Pickett Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2 Proc Natl Acad Sci U S A 97 2000 12475 12480
103. H.C. Huang, T. Nguyen, and C.B. Pickett Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription J Biol Chem 277 2002 42769 42774
104. S.P. Hussain, and C.C. Harris Inflammation and cancer: an ancient link with novel potentials Int J Cancer 121 2007 2373 2380
105. K. Iida, K. Itoh, Y. Kumagai, R. Oyasu, K. Hattori, and K. Kawai Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis Cancer Res 64 2004 6424 6431
106. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, and Y. Katoh An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem Biophys Res Commun 236 1997 313 322
107. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, and J.D. Engel Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev 13 1999 76 86
108. A. Izzotti, G.A. Calin, V.E. Steele, C. Cartiglia, M. Longobardi, and C.M. Croce Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs Cancer Prev Res (Phila) 3 2010 62 72
109. T. Jacks, and R.A. Weinberg Taking the study of cancer cell survival to a new dimension Cell 111 2002 923 925
110. A.K. Jain, and A.K. Jaiswal GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2 J Biol Chem 282 2007 16502 16510
111. J.H. Jang, and Y.J. Surh Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells Mutat Res Genet Toxicol Environ Mutagen 496 2001 181 190
112. T. Jenuwein, and C.D. Allis Translating the histone code Science 293 2001 1074 1080
113. W.S. Jeong, M. Jun, and A.N. Kong Nrf2: a potential molecular target for cancer chemoprevention by natural compounds Antioxid Redox Signal 8 2006 99 106
114. W.S. Jeong, Y.S. Keum, C. Chen, M.R. Jain, G. Shen, and J.H. Kim Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells J Biochem Mol Biol 38 2005 167 176
115. N. Jing, and D.J. Tweardy Targeting Stat3 in cancer therapy Anticancer Drugs 16 2005 601 607
116. P.A. Johnston, and J.R. Grandis STAT3 signaling: anticancer strategies and challenges Mol Interv 11 2011 18 26
117. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat Rev Genet 3 2002 415 428
118. P.L. Jones, G.J.C. Veenstra, P.A. Wade, D. Vermaak, S.U. Kass, and N. Landsberger Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription Nat Genet 19 1998 187 191
119. R.S. Jope, C.J. Yuskaitis, and E. Beurel Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics Neurochem Res 32 2007 577 595
120. Z.S. Kai, and A.E. Pasquinelli MicroRNA assassins: factors that regulate the disappearance of miRNAs Nat Struct Mol Biol 17 2010 5 10
121. K.W. Kang, S.H. Choi, and S.G. Kim Peroxynitrite activates NF-E2-related factor 2/antioxidant response element through the pathway of phosphatidylinositol 3-kinase: the role of nitric oxide synthase in rat glutathione S-transferase A2 induction Nitric Oxide 7 2002 244 253
122. K.W. Kang, S.J. Lee, J.W. Park, and S.G. Kim Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress Mol Pharmacol 62 2002 1001 1010
123. J.W. Kaspar, S.K. Niture, and A.K. Jaiswal Nrf2:INrf2 (Keap1) signaling in oxidative stress Free Radic Biol Med 47 2009 1304 1309
124. Y. Kato, R.I. Tapping, S. Huang, M.H. Watson, R.J. Ulevitch, and J.D. Lee Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor Nature 395 1998 713 716
125. T.W. Kensler, T.J. Curphey, Y. Maxiutenko, and B.D. Roebuck Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins Drug Metabol Drug Interact 17 2000 3 22
126. Y.S. Keum, W.S. Jeong, and A.N. Kong Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms Mutat Res 555 2004 191 202
127. Y.S. Keum, T.O. Khor, W. Lin, G. Shen, K.H. Kwon, and A. Barve Pharmacokinetics and pharmacodynamics of broccoli sprouts on the suppression of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: implication of induction of Nrf2, HO-1 and apoptosis and the suppression of Akt-dependent kinase pathway Pharm Res 26 2009 2324 2331
128. Y.-S. Keum, E.D. Owuor, B.-R. Kim, R. Hu, and A.N.T. Kong Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC) Pharm Res 20 2003 1351 1356
129. Y.S. Keum, S. Yu, P.P. Chang, X. Yuan, J.H. Kim, and C. Xu Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 Cells Cancer Res 66 2006 8804 8813
130. T.O. Khor, M.T. Huang, K.H. Kwon, J.Y. Chan, B.S. Reddy, and A.N. Kong Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis Cancer Res 66 2006 11580 11584
131. T.O. Khor, M.T. Huang, A. Prawan, Y. Liu, X. Hao, and S. Yu Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer Cancer Prev Res (Phila) 1 2008 187 191
132. T.O. Khor, Y. Huang, T.-Y. Wu, L. Shu, J. Lee, and A.-N.T. Kong Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation Biochem Pharmacol 82 2011 1073 1078
133. S. Khorasanizadeh The nucleosome: from genomic organization to genomic regulation Cell 116 2004 259 272
134. T. Kikuchi, F. Itoh, M. Toyota, H. Suzuki, H. Yamamoto, and M. Fujita Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer Int J Cancer 97 2002 272 277
135. N. Kikuno, H. Shiina, S. Urakami, K. Kawamoto, H. Hirata, and Y. Tanaka Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells Int J Cancer 123 2008 552 560
136. J.K. Kim, Y. Kim, K.M. Na, Y.J. Surh, and T.Y. Kim 6 -Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo Free Radic Res 41 2007 603 614
137. S.O. Kim, J.K. Kundu, Y.K. Shin, J.H. Park, M.H. Cho, and T.Y. Kim 6 -Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappa B in phorbol ester-stimulated mouse skin Oncogene 24 2005 2558 2567
138. Y.R. Kim, J.E. Oh, M.S. Kim, M.R. Kang, S.W. Park, and J.Y. Han Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin J Pathol 220 2010 446 451
139. A. King-Batoon, J.M. Leszczynska, and C.B. Klein Modulation of gene methylation by genistein or lycopene in breast cancer cells Environ Mol Mutagen 49 2008 36 45
140. Y. Kitamura, T. Umemura, K. Kanki, Y. Kodama, S. Kitamoto, and K. Saito Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino-3-methylimidazo[4,5-f]quinoline Cancer Sci 98 2007 19 24
141. A.N. Kong, S. Mandlekar, R. Yu, W. Lei, and A. Fasanmande Pharmacodynamics and toxicodynamics of drug action: signaling in cell survival and cell death Pharm Res 16 1999 790 798
142. A.N. Kong, E. Owuor, R. Yu, V. Hebbar, C. Chen, and R. Hu Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE) Drug Metab Rev 33 2001 255 271
143. A.N. Kong, R. Yu, V. Hebbar, C. Chen, E. Owuor, and R. Hu Signal transduction events elicited by cancer prevention compounds Mutat Res 480-481 2001 231 241
144. A.N. Kong, R. Yu, W. Lei, S. Mandlekar, T.H. Tan, and D.S. Ucker Differential activation of MAPK and ICE/Ced-3 protease in chemical-induced apoptosis. The role of oxidative stress in the regulation of mitogen-activated protein kinases (MAPKs) leading to gene expression and survival or activation of caspases leading to apoptosis Restor Neurol Neurosci 12 1998 63 70
145. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
146. K. Kudoh, M. Ramanna, R. Ravatn, A.G. Elkahloun, M.L. Bittner, and P.S. Meltzer Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray Cancer Res 60 2000 4161 4166
147. M.K. Kwak, P.A. Egner, P.M. Dolan, M. Ramos-Gomez, J.D. Groopman, and K. Itoh Role of phase 2 enzyme induction in chemoprotection by dithiolethiones Mutat Res 480-481 2001 305 315
148. J.M. Kyriakis, P. Banerjee, E. Nikolakaki, T. Dai, E.A. Rubie, and M.F. Ahmad The stress-activated protein kinase subfamily of c-Jun kinases Nature 369 1994 156 160
149. T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, and J. Caceres-Cortes A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 1994 645 648
150. A. Lau, N.F. Villeneuve, Z. Sun, P.K. Wong, and D.D. Zhang Dual roles of Nrf2 in cancer Pharmacol Res 58 2008 262 270
151. R.C. Lee, R.L. Feinbaum, and V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854
152. J.M. Lee, J.M. Hanson, W.A. Chu, and J.A. Johnson Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells J Biol Chem 276 2001 20011 20016
153. J.C. Lee, J.T. Laydon, P.C. McDonnell, T.F. Gallagher, S. Kumar, and D. Green A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 372 1994 739 746
154. J.D. Lee, R.J. Ulevitch, and J. Han Primary structure of BMK1: a new mammalian map kinase Biochem Biophys Res Commun 213 1995 715 724
155. M.S. Lee, J.C. Yuet-Wa, S.K. Kong, B. Yu, V.O. Eng-Choon, and H.W. Nai-Ching Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft Cancer Biol Ther 4 2005 1248 1254
156. W.J. Lee, and B.T. Zhu Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols Carcinogenesis 27 2006 269 277
157. R.J. Leeman, V.W. Lui, and J.R. Grandis STAT3 as a therapeutic target in head and neck cancer Expert Opin Biol Ther 6 2006 231 241
158. R.J. Leeman-Neill, Q. Cai, S.C. Joyce, S.M. Thomas, N.E. Bhola, and D.B. Neill Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors Clin Cancer Res 16 2010 2571 2579
159. J. Lessard, and G. Sauvageau Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells Nature 423 2003 255 260
160. A. Letai Pharmacological manipulation of Bcl-2 family members to control cell death J Clin Invest 115 2005 2648 2655
161. C. Leung, M. Lingbeek, O. Shakhova, J. Liu, E. Tanger, and P. Saremaslani Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas Nature 428 2004 337 341
162. J.D. Lewis, R.R. Meehan, W.J. Henzel, I. Maurer-Fogy, P. Jeppesen, and F. Klein Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA Cell 69 1992 905 914
163. Y.W. Li, F. Ahmed, S. Ali, P.A. Philip, O. Kucuk, and F.H. Sarkar Inactivation of nuclear factor kappa B by soy isoflavone genistein contributes to increased apoptosis mduced by chemotherapeutic agents in human cancer cells Cancer Res 65 2005 6934 6942
164. B. Li, M. Carey, and J.L. Workman The role of chromatin during transcription Cell 128 2007 707 719
165. C. Li, D.G. Heidt, P. Dalerba, C.F. Burant, L. Zhang, and V. Adsay Identification of pancreatic cancer stem cells Cancer Res 67 2007 1030 1037
166. W. Li, and A.N. Kong Molecular mechanisms of Nrf2-mediated antioxidant response Mol Carcinog 48 2009 91 104
167. Y. Li, D. Kong, Z. Wang, and F.H. Sarkar Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research Pharm Res 27 2010 1027 1041
168. L.Y. Li, X. Luo, and X. Wang Endonuclease G is an apoptotic DNase when released from mitochondria Nature 412 2001 95 99
169. W. Li, N. Thakor, E.Y. Xu, Y. Huang, C. Chen, and R. Yu An internal ribosomal entry site mediates redox-sensitive translation of Nrf2 Nucleic Acids Res 38 2010 778 788
170. Y. Li, and T.O. Tollefsbol Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components Curr Med Chem 17 2010 2141 2151
171. Y. Li, T.G. Vandenboom II, Z. Wang, D. Kong, S. Ali, and P.A. Philip miR-146a suppresses invasion of pancreatic cancer cells Cancer Res 70 2010 1486 1495
172. A. Lin Activation of the JNK signaling pathway: breaking the brake on apoptosis Bioessays 25 2003 17 24
173. W. Lin, R.T. Wu, T. Wu, T.O. Khor, H. Wang, and A.N. Kong Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway Biochem Pharmacol 76 2008 967 973
174. J. Liu, and A. Lin Role of JNK activation in apoptosis: a double-edged sword Cell Res 15 2005 36 42
175. K. Luger, A.W. Mader, R.K. Richmond, D.F. Sargent, and T.J. Richmond Crystal structure of the nucleosome core particle at 2.8 A resolution Nature 389 1997 251 260
176. A.H. Lund, and M. van Lohuizen Epigenetics and cancer Genes Dev 18 2004 2315 2335
177. Q. Ma Transcriptional responses to oxidative stress: pathological and toxicological implications Pharmacol Ther 125 2010 376 393
178. D.D. Ma, H.X. Lu, L.S. Xu, and W. Xiao Polyphyllin D exerts potent anti-tumour effects on Lewis cancer cells under hypoxic conditions J Int Med Res 37 2009 631 640
179. K. Maheo, F. Morel, S. Langouet, H. Kramer, E. Le Ferrec, and B. Ketterer Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes Cancer Res 57 1997 3649 3652
180. S. Majid, N. Kikuno, J. Nelles, E. Noonan, Y. Tanaka, and K. Kawamoto Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification Cancer Res 68 2008 2736 2744
181. C.J. Marshall MAP kinase kinase kinase, MAP kinase kinase and MAP kinase Curr Opin Genet Dev 4 1994 82 89
182. J.M. Marzec, J.D. Christie, S.P. Reddy, A.E. Jedlicka, H. Vuong, and P.N. Lanken Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury FASEB J 21 2007 2237 2246
183. S.M. Meeran, S.N. Patel, and T.O. Tollefsbol Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines PLoS One 5 2010 e11457
184. R. Mishra Glycogen synthase kinase 3 beta: can it be a target for oral cancer Mol Cancer 9 2010 144
185. D. Mizrak, M. Brittan, and M.R. Alison CD133: molecule of the moment J Pathol 214 2008 3 9
186. H. Motohashi, and M. Yamamoto Nrf2-Keap1 defines a physiologically important stress response mechanism Trends Mol Med 10 2004 549 557
187. M.C. Myzak, P. Tong, W.M. Dashwood, R.H. Dashwood, and E. Ho Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects Exp Biol Med (Maywood) 232 2007 227 234
188. H.K. Na, E.H. Kim, J.H. Jung, H.H. Lee, J.W. Hyun, and Y.J. Surh (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells Arch Biochem Biophys 476 2008 171 177
189. S. Nair, A. Barve, T.O. Khor, G.X. Shen, W. Lin, and J.Y. Chan Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells Acta Pharmacol Sin 31 2010 1223 1240
190. S. Nair, S.T. Doh, J.Y. Chan, A.N. Kong, and L. Cai Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis Br J Cancer 99 2008 2070 2082
191. S. Nair, C. Xu, G. Shen, V. Hebbar, A. Gopalakrishnan, and R. Hu Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice Pharm Res 23 2006 2621 2637
192. S. Nakahara, K. Yone, T. Sakou, S. Wada, T. Nagamine, and T. Niiyama Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis J Neuropathol Exp Neurol 58 1999 442 450
193. Y. Nakamura, M. Kawakami, A. Yoshihiro, N. Miyoshi, H. Ohigashi, and K. Kawai Involvement of the mitochondrial death pathway in chemopreventive benzyl isothiocyanate-induced apoptosis J Biol Chem 277 2002 8492 8499
194. Y. Nakamura, H. Ohigashi, S. Masuda, A. Murakami, Y. Morimitsu, and Y. Kawamoto Redox regulation of glutathione S-transferase induction by benzyl isothiocyanate: correlation of enzyme induction with the formation of reactive oxygen intermediates Cancer Res 60 2000 219 225
195. H. Nakano, A. Nakajima, S. Sakon-Komazawa, J.H. Piao, X. Xue, and K. Okumura Reactive oxygen species mediate crosstalk between NF-kappaB and JNK Cell Death Differ 13 2006 730 737
196. K. Nakaso, H. Yano, Y. Fukuhara, T. Takeshima, K. Wada-Isoe, and K. Nakashima PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells FEBS Lett 546 2003 181 184
197. X. Nan, H.H. Ng, C.A. Johnson, C.D. Laherty, B.M. Turner, and R.N. Eisenman Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex Nature 393 1998 386 389
198. V. Nandakumar, M. Vaid, and S.K. Katiyar (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells Carcinogenesis 32 2011 537 544
199. C. Nathan, and A. Ding SnapShot: reactive oxygen intermediates (ROI) Cell 140 951-951 2010 e952
200. M. Negrini, M. Ferracin, S. Sabbioni, and C.M. Croce MicroRNAs in human cancer: from research to therapy J Cell Sci 120 2007 1833 1840
201. G.N. Nithianandarajah-Jones, B. Wilm, C.E. Goldring, J. Muller, and M.J. Cross ERK5: structure, regulation and function Cell Signal 24 2012 2187 2196
202. S.K. Niture, A.K. Jain, P.M. Shelton, and A.K. Jaiswal Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression J Biol Chem 286 2011 28821 28832
203. S. Numazawa, M. Ishikawa, A. Yoshida, S. Tanaka, and T. Yoshida Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress Am J Physiol Cell Physiol 285 2003 C334 C342
204. E.F. Nuwaysir, M. Bittner, J. Trent, J.C. Barrett, and C.A. Afshari Microarrays and toxicology: the advent of toxicogenomics Mol Carcinog 24 1999 153 159
205. C.A. O'Brien, A. Pollett, S. Gallinger, and J.E. Dick A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106 110
206. S. Ogino, T. Kawasaki, G.J. Kirkner, P. Kraft, M. Loda, and C.S. Fuchs Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample J Mol Diagn 9 2007 305 314
207. V. Orlando Polycomb, epigenomes, and control of cell identity Cell 112 2003 599 606
208. W.O. Osburn, B. Karim, P.M. Dolan, G. Liu, M. Yamamoto, and D.L. Huso Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment Int J Cancer 121 2007 1883 1891
209. B. Padmanabhan, K.I. Tong, T. Ohta, Y. Nakamura, M. Scharlock, and M. Ohtsuji Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer Mol Cell 21 2006 689 700
210. P. Palozza, R. Simone, A. Catalano, A. Boninsegna, V. Bohm, and K. Frohlich Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages J Nutr Biochem 21 2010 34 46
211. M. Pandey, S. Shukla, and S. Gupta Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells Int J Cancer 126 2010 2520 2533
212. I.K. Park, D. Qian, M. Kiel, M.W. Becker, M. Pihalja, and I.L. Weissman Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells Nature 423 2003 302 305
213. A.E. Pasquinelli, B.J. Reinhart, F. Slack, M.Q. Martindale, M.I. Kuroda, and B. Maller Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA Nature 408 2000 86 89
214. G. Paul, F. Bataille, F. Obermeier, J. Bock, F. Klebl, and U. Strauch Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis Clin Exp Immunol 140 2005 547 555
215. I.P. Pogribny, S.J. James, and F.A. Beland Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency Mol Nutr Food Res 56 2012 116 125
216. I.P. Pogribny, S.J. James, S. Jernigan, and M. Pogribna Genomic hypomethylation is specific for preneoplastic liver in folate/methyl deficient rats and does not occur in non-target tissues Mutat Res Fundam Mol Mech Mutagen 548 2004 53 59
217. B. Pool-Zobel, S. Veeriah, and F.D. Bohmer Modulation of xenobiotic metabolising enzymes by anticarcinogens - focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis Mutat Res 591 2005 74 92
218. F.M. Raaphorst, A.P. Otte, and C.J. Meijer Polycomb-group genes as regulators of mammalian lymphopoiesis Trends Immunol 22 2001 682 690
219. P. Rada, A.I. Rojo, S. Chowdhry, M. McMahon, J.D. Hayes, and A. Cuadrado SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner Mol Cell Biol 31 2011 1121 1133
220. P.T. Ram, and R. Iyengar G protein coupled receptor signaling through the Src and Stat3 pathway: role in proliferation and transformation Oncogene 20 2001 1601 1606
221. M. Raman, W. Chen, and M.H. Cobb Differential regulation and properties of MAPKs Oncogene 26 2007 3100 3112
222. M. Ramos-Gomez, M.K. Kwak, P.M. Dolan, K. Itoh, M. Yamamoto, and P. Talalay Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor-deficient mice Proc Natl Acad Sci U S A 98 2001 3410 3415
223. L. Raptis, R. Arulanandam, M. Geletu, and J. Turkson The R(h)oads to Stat3: Stat3 activation by the Rho GTPases Exp Cell Res 317 2011 1787 1795
224. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
225. D. Rimoldi, V. Srikantan, V.L. Wilson, R.H. Bassin, and D. Samid Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2′-deoxycytidine Cancer Res 51 1991 324 330
226. D. Rodenhiser, and M. Mann Epigenetics and human disease: translating basic biology into clinical applications CMAJ 174 2006 341 348
227. I. Rodriguez-Ramiro, S. Ramos, L. Bravo, L. Goya, and M.A. Martin Procyanidin B2 induces Nrf2 translocation and glutathione S-transferase P1 expression via ERKs and p38-MAPK pathways and protect human colonic cells against oxidative stress Eur J Nutr 51 7 2012 881 892 (Electronic publication ahead of print)
228. A.I. Rojo, P. Rada, J. Egea, A.O. Rosa, M.G. Lopez, and A. Cuadrado Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death Mol Cell Neurosci 39 2008 125 132
229. T.H. Rushmore, and A.N. Kong Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes Curr Drug Metab 3 2002 481 490
230. M. Saitoh, H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, and Y. Sawada Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 EMBO J 17 1998 2596 2606
231. M. Salazar, A.I. Rojo, D. Velasco, R.M. de Sagarra, and A. Cuadrado Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2 J Biol Chem 281 2006 14841 14851
232. P. Sarti, L. Avigliano, A. Gorlach, and B. Brune Superoxide and nitric oxide-participation in cell communication Cell Death Differ 9 2002 1160 1162
233. C.L. Saw, M.T. Huang, Y. Liu, T.O. Khor, A.H. Conney, and A.N. Kong Impact of Nrf2 on UVB-induced skin inflammation/photoprotection and photoprotective effect of sulforaphane Mol Carcinog 50 2011 479 486
234. T. Schatton, G.F. Murphy, N.Y. Frank, K. Yamaura, A.M. Waaga-Gasser, and M. Gasser Identification of cells initiating human melanomas Nature 451 2008 345 349
235. M. Schena, D. Shalon, R.W. Davis, and P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 1995 467 470
236. A.J. Schetter, N.H. Heegaard, and C.C. Harris Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways Carcinogenesis 31 2010 37 49
237. L. Scorrano, S.A. Oakes, J.T. Opferman, E.H. Cheng, M.D. Sorcinelli, and T. Pozzan BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis Science 300 2003 135 139
238. G. Shen, V. Hebbar, S. Nair, C. Xu, W. Li, and W. Lin Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein J Biol Chem 279 2004 23052 23060
239. G. Shen, C. Xu, R. Hu, M.R. Jain, A. Gopalkrishnan, and S. Nair Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin Mol Cancer Ther 5 2006 39 51
240. G. Shen, C. Xu, R. Hu, M.R. Jain, S. Nair, and W. Lin Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice Pharm Res 22 2005 1805 1820
241. Y. Shi Histone lysine demethylases: emerging roles in development, physiology and disease Nat Rev Genet 8 2007 829 833
242. T. Shibata, A. Kokubu, S. Saito, M. Narisawa-Saito, H. Sasaki, and K. Aoyagi NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer Neoplasia 13 2011 864 873
243. T. Shibata, T. Ohta, K.I. Tong, A. Kokubu, R. Odogawa, and K. Tsuta Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy Proc Natl Acad Sci U S A 105 2008 13568 13573
244. L. Shu, K.L. Cheung, T.O. Khor, C. Chen, and A.N. Kong Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis Cancer Metastasis Rev 29 2010 483 502
245. L. Shu, T.O. Khor, J.H. Lee, S.S. Boyanapalli, Y. Huang, and T.Y. Wu Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells AAPS J 13 2011 606 614
246. S.K. Singh, I.D. Clarke, M. Terasaki, V.E. Bonn, C. Hawkins, and J. Squire Identification of a cancer stem cell in human brain tumors Cancer Res 63 2003 5821 5828
247. A. Singh, V. Misra, R.K. Thimmulappa, H. Lee, S. Ames, and M.O. Hoque Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer PLoS Med 3 2006 e420
248. S.J. Sohn, B.K. Sarvis, D. Cado, and A. Winoto ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression J Biol Chem 277 2002 43344 43351
249. M.R. Sprick, and H. Walczak The interplay between the Bcl-2 family and death receptor-mediated apoptosis Biochim Biophys Acta 1644 2004 125 132
250. D. Stokoe, S.G. Macdonald, K. Cadwallader, M. Symons, and J.F. Hancock Activation of Raf as a result of recruitment to the plasma membrane Science 264 1994 1463 1467
251. M. Sun, Z. Estrov, Y. Ji, K.R. Coombes, D.H. Harris, and R. Kurzrock Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells Mol Cancer Ther 7 2008 464 473
252. Z. Sun, Z. Huang, and D.D. Zhang Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response PLoS One 4 2009 e6588
253. Y.L. Sun, X.F. Jiang, S.J. Chen, and B.D. Price Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation FEBS Lett 580 2006 4353 4356
254. B. Sung, M.K. Pandey, K.S. Ahn, T.F. Yi, M.M. Chaturvedi, and M.Y. Liu Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappa B-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappa B alpha kinase, leading to potentiation of apoptosis Blood 111 2008 4880 4891
255. M. Suzuki, R.J. Youle, and N. Tjandra Structure of Bax: coregulation of dimer formation and intracellular localization Cell 103 2000 645 654
256. P. Talalay Chemoprotection against cancer by induction of phase 2 enzymes Biofactors 12 2000 5 11
257. W. Tang, J.W. Liu, W.M. Zhao, D.Z. Wei, and J.J. Zhong Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells Life Sci 80 2006 205 211
258. R.K. Thimmulappa, K.H. Mai, S. Srisuma, T.W. Kensler, M. Yamamoto, and S. Biswal Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray Cancer Res 62 2002 5196 5203
259. I. Tinhofer, D. Bernhard, M. Senfter, G. Anether, M. Loeffler, and G. Kroemer Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2 FASEB J 15 2001 1613 1615
260. D.J. Tremethick Higher-order structures of chromatin: the elusive 30 nm fiber Cell 128 2007 651 654
261. W.P. Tsang, and T.T. Kwok Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells J Nutr Biochem 21 2010 140 146
262. M.E. Valk-Lingbeek, S.W. Bruggeman, and M. van Lohuizen Stem cells and cancer; the polycomb connection Cell 118 2004 409 418
263. N.M. van der Lugt, J. Domen, K. Linders, M. van Roon, E. Robanus-Maandag, and H. te Riele Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene Genes Dev 8 1994 757 769
264. J.E. Visvader, and G.J. Lindeman Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat Rev Cancer 8 2008 755 768
265. D.W. Voehringer, D.L. Hirschberg, J. Xiao, Q. Lu, M. Roederer, and C.B. Lock Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis Proc Natl Acad Sci U S A 97 2000 2680 2685
266. N. Wakabayashi, A.T. Dinkova-Kostova, W.D. Holtzclaw, M.I. Kang, A. Kobayashi, and M. Yamamoto Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers Proc Natl Acad Sci U S A 101 2004 2040 2045
267. X. Wang The expanding role of mitochondria in apoptosis Genes Dev 15 2001 2922 2933
268. R. Wang, J. An, F. Ji, H. Jiao, H. Sun, and D. Zhou Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues Biochem Biophys Res Commun 373 2008 151 154
269. L.G. Wang, A. Beklemisheva, X.M. Liu, A.C. Ferrari, J. Feng, and J.W. Chiao Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer Mol Carcinog 46 2007 24 31
270. H. Wang, T.O. Khor, C.L. Saw, W. Lin, T. Wu, and Y. Huang Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid Mol Pharm 7 2010 2185 2193
271. L.G. Wang, X.M. Liu, Y. Fang, W. Dai, F.B. Chiao, and G.M. Puccio De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc Int J Oncol 33 2008 375 380
272. J.H. Wang, M.Z. Yao, Z.L. Zhang, Y.H. Zhang, Y.G. Wang, and X.Y. Liu HSF1 blockade-induced tumor thermotolerance abolishment is mediated by JNK-dependent caspase-3 activation Biochem Biophys Res Commun 321 2004 736 745
273. L.W. Wattenberg Chemoprophylaxis of carcinogenesis: a review Cancer Res 26 1966 1520 1526
274. M. Widschwendter, H. Fiegl, D. Egle, E. Mueller-Holzner, G. Spizzo, and C. Marth Epigenetic stem cell signature in cancer Nat Genet 39 2007 157 158
275. J. Winter, S. Jung, S. Keller, R.I. Gregory, and S. Diederichs Many roads to maturity: microRNA biogenesis pathways and their regulation Nat Cell Biol 11 2009 228 234
276. A.P. Wolffe, and M.A. Matzke Epigenetics: regulation through repression Science 286 1999 481 486
277. T.Y. Wu, T.O. Khor, C.L. Saw, S.C. Loh, A.I. Chen, and S.S. Lim Anti-inflammatory/Anti-oxidative stress activities and differential regulation of Nrf2-mediated genes by non-polar fractions of tea Chrysanthemum zawadskii and licorice Glycyrrhiza uralensis AAPS J 13 2011 1 13
278. C. Xu, M.T. Huang, G. Shen, X. Yuan, W. Lin, and T.O. Khor Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2 Cancer Res 66 2006 8293 8296
279. C. Xu, X. Yuan, Z. Pan, G. Shen, J.H. Kim, and S. Yu Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2 Mol Cancer Ther 5 2006 1918 1926
280. T. Yamamoto, K. Yoh, A. Kobayashi, Y. Ishii, S. Kure, and A. Koyama Identification of polymorphisms in the promoter region of the human NRF2 gene Biochem Biophys Res Commun 321 2004 72 79
281. Z.F. Yang, D.W. Ho, M.N. Ng, C.K. Lau, W.C. Yu, and P. Ngai Significance of CD90+ cancer stem cells in human liver cancer Cancer Cell 13 2008 153 166
282. C.B. Yoo, and P.A. Jones Epigenetic therapy of cancer: past, present and future Nat Rev Drug Discov 5 2006 37 50
283. B.P. Yu Cellular defenses against damage from reactive oxygen species Physiol Rev 74 1994 139 162
284. R. Yu, C. Chen, Y.Y. Mo, V. Hebbar, E.D. Owuor, and T.H. Tan Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism J Biol Chem 275 2000 39907 39913
285. H. Yu, and R. Jove The STATs of cancer - new molecular targets come of age Nat Rev Cancer 4 2004 97 105
286. X. Yu, and T. Kensler Nrf2 as a target for cancer chemoprevention Mutat Res 591 2005 93 102
287. S.W. Yu, T.O. Khor, K.L. Cheung, W.G. Li, T.Y. Wu, and Y. Huang Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice PLoS One 5 2010
288. R. Yu, W. Lei, S. Mandlekar, M.J. Weber, C.J. Der, and J. Wu Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals J Biol Chem 274 1999 27545 27552
289. R. Yu, S. Mandlekar, K.J. Harvey, D.S. Ucker, and A.N. Kong Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity Cancer Res 58 1998 402 408
290. R. Yu, S. Mandlekar, W. Lei, W.E. Fahl, T.H. Tan, and A.N. Kong p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens J Biol Chem 275 2000 2322 2327
291. C. Zhang, B. Li, X. Zhang, P. Hazarika, B.B. Aggarwal, and M. Duvic Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling J Invest Dermatol 130 2010 2110 2119
292. B. Zhang, X. Pan, G.P. Cobb, and T.A. Anderson MicroRNAs as oncogenes and tumor suppressors Dev Biol 302 2007 1 12
293. P. Zhang, A. Singh, S. Yegnasubramanian, D. Esopi, P. Kombairaju, and M. Bodas Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth Mol Cancer Ther 9 2010 336 346
294. X. Zhang, J. Zhang, L. Wang, H. Wei, and Z. Tian Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice BMC Cancer 7 2007 149
295. Y. Zhao, Y. Xue, T.D. Oberley, K.K. Kiningham, S.M. Lin, and H.C. Yen Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model Cancer Res 61 2001 6082 6088
296. G. Zhou, Z.Q. Bao, and J.E. Dixon Components of a new human protein kinase signal transduction pathway J Biol Chem 270 1995 12665 12669
297. L.M. Zipper, and R.T. Mulcahy Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes Biochem Biophys Res Commun 278 2000 484 492
298. L.M. Zipper, and R.T. Mulcahy Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells Toxicol Sci 73 2003 124 134